Effect of caffeine on long-term potentiation-like effects induced by quadripulse transcranial magnetic stimulation.


Journal

Experimental brain research
ISSN: 1432-1106
Titre abrégé: Exp Brain Res
Pays: Germany
ID NLM: 0043312

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 16 10 2018
accepted: 06 12 2018
pubmed: 12 12 2018
medline: 14 6 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Caffeine, an adenosine receptor antagonist, is known to affect sleep-awake cycles, the stress response, and learning and memory. It has been suggested that caffeine influences synaptic plasticity, but the effects of caffeine on synaptic plasticity in the human brain remain unexplored. The present study aimed to investigate the effects of caffeine on long-term potentiation (LTP)-like effects in the primary motor cortex of healthy humans. Twelve healthy participants (six women and six men; mean age: 44.8 ± 1.5 years) underwent quadripulse magnetic stimulation with an inter-stimulus interval of 5 ms (QPS5) to induce LTP-like effects, 2 h after administration of either a caffeine (200 mg) or placebo tablet in a double-blind crossover design. We recorded motor-evoked potentials (MEPs) before and after QPS5. The degree of MEP enhancement was compared between the placebo and caffeine conditions. Neither active nor resting motor thresholds were influenced by caffeine administration. Following caffeine administration, the degree of potentiation significantly decreased in "significant responders", whose average MEP ratios were greater than 1.24 in the placebo condition. The observed reduction in potentiation following caffeine administration is consistent with the A

Identifiants

pubmed: 30535949
doi: 10.1007/s00221-018-5450-9
pii: 10.1007/s00221-018-5450-9
doi:

Substances chimiques

Purinergic P1 Receptor Antagonists 0
Caffeine 3G6A5W338E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

647-651

Subventions

Organisme : the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology
ID : 26461308,17K09809, 15H05881
Organisme : the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology
ID : 15H05881, 25293206, 22390181, 16H05322
Organisme : the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology
ID : 16K09709, 16H01497, 22590954
Organisme : Descartes Centre voor Wetenschapsgeschiedenis en Wetenschapsfilosofie, Universiteit Utrecht (NL)
ID : non
Organisme : the Magnetic Health Science Foundation
ID : non
Organisme : Dainippon Sumitomo Pharma
ID : non
Organisme : GlaxoSmithKline (GB)
ID : non

Références

Pharmacol Rev. 1999 Mar;51(1):83-133
pubmed: 10049999
J Appl Physiol (1985). 1999 Aug;87(2):801-8
pubmed: 10444642
Brain Res. 1999 Dec 18;851(1-2):228-34
pubmed: 10642848
Neurology. 2002 Apr 23;58(8):1154-60
pubmed: 11971080
Clin Neurophysiol. 2005 Feb;116(2):308-14
pubmed: 15661109
J Neurosci. 2006 Feb 15;26(7):2080-7
pubmed: 16481441
Neurophysiol Clin. 2006 Jul-Aug;36(4):219-26
pubmed: 17095411
Neuron. 2008 Jan 10;57(1):121-34
pubmed: 18184569
J Physiol. 2008 Aug 15;586(16):3927-47
pubmed: 18599542
Neuropsychopharmacology. 2009 Jun;34(7):1865-74
pubmed: 19212319
Clin Neurophysiol. 2009 Dec;120(12):2008-2039
pubmed: 19833552
J Alzheimers Dis. 2010;20 Suppl 1:S63-9
pubmed: 20164574
J Alzheimers Dis. 2010;20 Suppl 1:S25-34
pubmed: 20182030
Brain Stimul. 2008 Jul;1(3):164-82
pubmed: 20633383
J Physiol. 2010 Sep 15;588(Pt 18):3415-24
pubmed: 20660568
J Neurosci. 2011 Apr 6;31(14):5294-9
pubmed: 21471364
Eur J Neurosci. 2011 Jul;34(1):12-21
pubmed: 21615561
Mov Disord. 2011 Nov;26(13):2427-31
pubmed: 21953603
Neurology. 2012 Aug 14;79(7):651-8
pubmed: 22855866
Mov Disord. 2013 Jul;28(8):1138-41
pubmed: 23483627
Behav Brain Res. 2014 May 1;264:116-25
pubmed: 24525422
Int Rev Neurobiol. 2014;119:257-307
pubmed: 25175970
J Neural Transm (Vienna). 2015 Sep;122(9):1253-61
pubmed: 25663170
Nat Neurosci. 2015 Sep;18(9):1299-1309
pubmed: 26237365
Brain Stimul. 2015 Nov-Dec;8(6):1220-2
pubmed: 26250722
Brain Stimul. 2016 Nov - Dec;9(6):859-866
pubmed: 27692928
Exp Brain Res. 2017 Jul;235(7):2103-2108
pubmed: 28386713
Physiol Behav. 2017 Oct 1;179:361-368
pubmed: 28694153
Physiol Rep. 2018 Mar;6(5):
pubmed: 29512310
Psychopharmacology (Berl). 1988;94(1):38-45
pubmed: 3126526
Cell Mol Neurobiol. 1983 Mar;3(1):69-80
pubmed: 6309393
Br J Pharmacol. 1996 Jul;118(6):1461-8
pubmed: 8832073
Electroencephalogr Clin Neurophysiol. 1998 Jan;108(1):1-16
pubmed: 9474057

Auteurs

Ritsuko Hanajima (R)

Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, Japan. hanajima-tky@umin.ac.jp.
Department of Neurology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan. hanajima-tky@umin.ac.jp.

Nobuyuki Tanaka (N)

Department of Neurology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Ryosuke Tsutsumi (R)

Department of Neurology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Yuichiro Shirota (Y)

Department of Neurology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Takahiro Shimizu (T)

Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, Japan.
Department of Neurology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.

Yasuo Terao (Y)

Department of Neurology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.
Department of Cell Physiology, Kyorin University, 6-20-2 Shinkawa, Mitaka, Tokyo, Japan.

Yoshikazu Ugawa (Y)

Department of Neuro-Regeneration, Fukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH